	Clinical and dosimetric feasibility of sparing submandibular gland in patients with oral cavity squamous cell carcinoma. Ann Med He YP, Zhou P, Guan LM, Wu SG. PMID: 39707740 [PubMed - indexed for MEDLINE]
	Epidemiological landscape of tongue cancer in younger patients in a National Cancer Center in Brazil. Sci Rep da Silva Souto AC, da Silva BNM, Heimlich FV, Soares OAB, Dias FL, de Lima Araujo LH, de Melo AC, Antunes HS, Santos Thuler LC, Goldemberg DC. PMID: 39706848 [PubMed - indexed for MEDLINE]
	From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy. Front Immunol Qiu Z, Li Z, Liu X, Zhang R, Li Y, Gao C, Mao X, Bao Y, Zhang M, Guo C. PMID: 39703499 [PubMed - indexed for MEDLINE]
	Clinical Outcomes and Prognosis of Esophageal Squamous Cell Carcinoma Presenting with Obstruction. J Gastrointest Cancer Ryu DG, Yu F, Liu H, Lee SS, Lee SL. PMID: 39702624 [PubMed - indexed for MEDLINE]
	Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma. Front Immunol Cai H, Chen L, Huang J, Ma H, Zhang S, Zhong K, Yang D, Sun J, Liu H, Song R. PMID: 39697347 [PubMed - indexed for MEDLINE]
	Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape. BMC Cancer Cheng X, Meng F, Wang R, Liu S, Li Q, Chen B, Xi M. PMID: 39696104 [PubMed - indexed for MEDLINE]
	Expression of mTOR, CD163, Î±-SMA, FOXp3 as survival predictors and its significance in patients with oral squamous cell carcinoma. BMC Oral Health Ramalingam S, Shantha S, Srinivasan CP, Priyathersini N, Muralitharan S, Sudhakar U, Thamizhchelvan H, Parvathi VD. PMID: 39695576 [PubMed - indexed for MEDLINE]
	Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat Zhang R, Liu J, Yang H, Tan J, Xiong R, Liu Y, Feng G, Song G, Liu K. PMID: 39692561 [PubMed - indexed for MEDLINE]
	A novel computational model ITHCS for enhanced prognostic risk stratification in ESCC by correcting for intratumor heterogeneity. Brief Bioinform Lu T, Guo W, Guo W, Meng W, Han T, Guo Z, Li C, Gao S, Ye Y, Li H. PMID: 39690882 [PubMed - indexed for MEDLINE]
	Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study. Front Immunol Zhou N, Hua Y, Ge Y, Wang Q, Wang C, He J, Zhao L, Yu S, Yan J, Zhao L, Li L, Bai C. PMID: 39687611 [PubMed - indexed for MEDLINE]
	Effect of Liquid Blood Concentrates on Cell Proliferation and Cell Cycle- and Apoptosis-Related Gene Expressions in Nonmelanoma Skin Cancer Cells: A Comparative In Vitro Study. Int J Mol Sci Dohle E, Zhu L, Sader R, Ghanaati S. PMID: 39684700 [PubMed - indexed for MEDLINE]
	Primary intraosseous squamous cell carcinoma originating from a mandibular odontogenic cyst: A case report. Sci Prog He Z, Tao Y, Li J, Shang W, Song K. PMID: 39682012 [PubMed - indexed for MEDLINE]
	Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy. Front Immunol Li HX, Gong YW, Yan PJ, Xu Y, Qin G, Wen WP, Teng FY. PMID: 39676875 [PubMed - indexed for MEDLINE]
	Severe postoperative complications after minimally invasive esophagectomy reduce the long-term prognosis of well-immunonutrition patients with locally advanced esophageal squamous cell carcinoma. Ann Med Chen C, Xu SJ, Zhang ZF, You CX, Luo YF, Chen RQ, Chen SC. PMID: 39673205 [PubMed - indexed for MEDLINE]
	Combination of anlotinib and sintilimab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma: a single-arm prospective study. Anticancer Drugs Wang T, Wang J, Zhang Y, Song Y, Xu G, Zhang B. PMID: 39671265 [PubMed - indexed for MEDLINE]
	Biological implications of decoding the extracellular matrix of vulva cancer. Oncol Rep Islam ME, Debnath KC, Moniruzzaman R, Okuyama K, Islam S, Dongre HN. PMID: 39670289 [PubMed - indexed for MEDLINE]
	MSR1 in lung squamous cell carcinoma: Prognostic and immunological values in pan-cancer and single-cell analyses and a cohort study. Int Immunopharmacol Bu Y, Liu Y, Hu C, Yuan D, Luo L, Li M, Hu J, Hang D, Xu Z. PMID: 39667048 [PubMed - indexed for MEDLINE]
	Exploring Oesophageal Cancer in Ethiopia: Elevated Incidence in Females and Younger Cases. Cancer Rep (Hoboken) Mulisa G, Abebe T, Gutema B, Mahmuda J, Khan MAA, Gheit T, Herceg Z, Talukdar FR. PMID: 39665274 [PubMed - indexed for MEDLINE]
	Prediction of relative survival trends in patients with cutaneous squamous cell carcinoma using a model-based period analysis: a retrospective analysis of the surveillance, epidemiology, and end results database. BMJ Open Zheng S, Yu H, Zhang J, Lau WC, Chen M, Cheng H, Xian H, Ming WK, Cheng LN, He Y, Huang S, Chen W, Lyu J, Deng L. PMID: 39663166 [PubMed - indexed for MEDLINE]
	Mast cells and factor XIIIa+ dendrocytes in actinic cheilitis and lip squamous cell carcinoma. Braz Oral Res Flores IL, de Arruda JAA, Abrantes TC, Gamba TO, Abrahão AC, Anbinder AL, Ribeiro JL, Vasconcelos ACU, Andrade BAB, Aguiar MCF, Gomes APN, Abreu LG, Mesquita RA. PMID: 39661794 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61417

Page 1 of 3071



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy